Pre-market trading saw mixed results on Tuesday, with Palantir leading the charge, up 11% after reporting record revenue of $1.41 billion. Capri Holdings, owner of Michael Kors, also gained ground, rising 1.8% on better-than-expected earnings. Meanwhile, Marathon Petroleum saw a 4.1% rise due to strong refining margins, adding to investor optimism.

On the downside, Merck fell 1% due to disappointing 2026 guidance, and Pfizer dropped 2.2% following a revenue decline. These shifts reflect investor reactions to recent earnings reports and forecasts. The broader market appears to be digesting a trade deal between the U.S. and India, adding complexity to the trading day.

Other notable movers included a 20% surge for Teradyne, fueled by robust demand in the chip-testing sector. JetBlue also saw a boost, up 2.5% after a Citigroup upgrade. Conversely, Archer-Daniels-Midland shares fell after projecting lower-than-expected profits. These movements underscore the importance of sector-specific performance amid broader market trends.